These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1220628)

  • 1. Influence of fluorostigmine on some parameters of the catecholaminergic and serotoninergic systems in the mouse brain.
    Kleinrok Z; Jagiello-Wójtowicz E; Sieklucka M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):769-76. PubMed ID: 1220628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluorostigmine, toxogonin and atropine on monoamine oxidase activity and the level of biogenic amines in mouse brain.
    Kleinrok Z; Jagiełło-Wójtowicz E; Sieklucka-Dziuba M
    Acta Physiol Pol; 1979; 30(4):437-44. PubMed ID: 388982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of amino acid imbalance on brain amines.
    Dalal BB; Chatterjee AK; Sadhu U
    Int J Vitam Nutr Res; 1987; 57(3):305-10. PubMed ID: 3119509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotoninergic and catecholaminergic indices in patients with neurotic and depressive disorders and changes in them as a result of reflexotherapy].
    Markelova VF; Belitskaia RA; Mikhaĭlova AA; Shumova OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1708-12. PubMed ID: 2433857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines.
    Gasull T; Giralt M; Garcia A; Hidalgo J
    Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine in aggressiveness.
    Valzelli L
    Adv Biochem Psychopharmacol; 1974; 11(0):255-63. PubMed ID: 4276860
    [No Abstract]   [Full Text] [Related]  

  • 15. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of catecholamines in the hypothermic activity of cannabis in albino rats.
    Singh PP; Das PK
    Psychopharmacology (Berl); 1976 Nov; 50(2):199-204. PubMed ID: 826962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse brain catecholamines, 5-hydroxytryptamine and the antinociceptive activity of pethidine.
    Pleuvry BJ
    Eur J Pharmacol; 1975 Dec; 34(2):351-61. PubMed ID: 1234554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of dfp, atropine and toxogonine on tryptophan pyrolase activity in mouse liver.
    Kleinrok Z; Jagiełlłlo-Wójtowicz E; Sieklucka-Dziuba M
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):829-37. PubMed ID: 348151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.